[HTML][HTML] Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
[HTML][HTML] Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
X Wen, YC Ou, G Bogatcheva, G Thomas… - Chemical …, 2020 - ncbi.nlm.nih.gov
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
[PDF][PDF] Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
X Wen, YC Ou, G Bogatcheva - pdfs.semanticscholar.org
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry.
X Wen, YC Ou, G Bogatcheva, G Thomas… - Chemical …, 2020 - europepmc.org
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
[PDF][PDF] Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
X Wen, YC Ou, G Bogatcheva, G Thomas… - researchgate.net
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
X Wen, YC Ou, G Bogatcheva, G Thomas… - Chemical …, 2020 - pubmed.ncbi.nlm.nih.gov
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
X Wen, YC Ou, G Bogatcheva, G Thomas… - Chemical Science, 2020 - Elsevier
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
[PDF][PDF] Probing metabolic alterations in breast cancer in response to molecular inhibitors with Raman spectroscopy and validated with mass spectrometry
X Wen, YC Ou, G Bogatcheva, G Thomas… - pdfs.semanticscholar.org
Rapid and accurate response to targeted therapies is critical to differentiate tumors that are
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …
resistant to treatment early in the regimen. In this work, we demonstrate a rapid, noninvasive …